Literature DB >> 15252182

Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.

Adam Gordon, Solomon Menahem, Joanne Mitchell, Peter Jenkins, John Dowling, Stuart K Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15252182     DOI： 10.1093/ndt/gfh336

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

Review 1.  De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

Authors:  Fabrizio Fabrizi; Alessio Aghemo; Gabriella Moroni; Patrizia Passerini; Roberta D'Ambrosio; Paul Martin; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.487

Review 2.  Anti-hepatitis C virus drugs and kidney.

Authors:  Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2016-11-18

Review 3.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

4.  Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature.

Authors:  Iacopo Gianassi; Marco Allinovi; Leonardo Caroti; Lino Calogero Cirami
Journal:  World J Nephrol       Date:  2019-11-12

5.  Hepatitis C as a potential cause of IgA nephropathy.

Authors:  A K Dey; A Bhattacharya; A Majumdar
Journal:  Indian J Nephrol       Date:  2013-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.